Cargando…

PET Imaging in Preclinical Anti-Aβ Drug Development

Positron emission tomography (PET), a medical imaging technique allowing for studies of the living human brain, has gained an important role in clinical trials of novel drugs against Alzheimer’s disease (AD). For example, PET data contributed to the conditional approval in 2021 of aducanumab, an ant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Syvänen, Stina, Meier, Silvio R., Roshanbin, Sahar, Xiong, Mengfei, Faresjö, Rebecca, Gustavsson, Tobias, Bonvicini, Gillian, Schlein, Eva, Aguilar, Ximena, Julku, Ulrika, Eriksson, Jonas, Sehlin, Dag
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Expert Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9246809/ https://www.ncbi.nlm.nih.gov/pubmed/35501533 http://dx.doi.org/10.1007/s11095-022-03277-z

Ejemplares similares

Brain pharmacokinetics of mono- and bispecific amyloid-β antibodies in wild-type and Alzheimer’s disease mice measured by high cut-off microdialysis
por: Julku, Ulrika, et al.
Publicado: (2022)

Reduction of αSYN Pathology in a Mouse Model of PD Using a Brain-Penetrating Bispecific Antibody
por: Roshanbin, Sahar, et al.
Publicado: (2022)

Brain pharmacokinetics of two BBB penetrating bispecific antibodies of different size
por: Faresjö, Rebecca, et al.
Publicado: (2021)

Antibody-Based In Vivo PET Imaging Detects Amyloid-β Reduction in Alzheimer Transgenic Mice After BACE-1 Inhibition
por: Meier, Silvio R., et al.
Publicado: (2018)

(11)C-PiB and (124)I-Antibody PET Provide Differing Estimates of Brain Amyloid-β After Therapeutic Intervention
por: Meier, Silvio R., et al.
Publicado: (2022)

Long-term effects of immunotherapy with a brain penetrating Aβ antibody in a mouse model of Alzheimer’s disease
por: Gustavsson, Tobias, et al.
Publicado: (2023)

Fluorine-18-Labeled Antibody Ligands for PET Imaging of Amyloid-β in Brain
por: Syvänen, Stina, et al.
Publicado: (2020)

Age, dose, and binding to TfR on blood cells influence brain delivery of a TfR-transported antibody
por: Faresjö, Rebecca, et al.
Publicado: (2023)

Engineered antibodies: new possibilities for brain PET?
por: Sehlin, Dag, et al.
Publicado: (2019)

Functionalization of Radiolabeled Antibodies to Enhance Peripheral Clearance for High Contrast Brain Imaging
por: Schlein, Eva, et al.
Publicado: (2022)

Pharmacokinetics, biodistribution and brain retention of a bispecific antibody-based PET radioligand for imaging of amyloid-β
por: Sehlin, Dag, et al.
Publicado: (2017)

ImmunoPET imaging of amyloid-beta in a rat model of Alzheimer’s disease with a bispecific, brain-penetrating fusion protein
por: Bonvicini, Gillian, et al.
Publicado: (2022)

Pinpointing Brain TREM2 Levels in Two Mouse Models of Alzheimer’s Disease
por: Meier, Silvio R., et al.
Publicado: (2021)

SPECT imaging of distribution and retention of a brain-penetrating bispecific amyloid-β antibody in a mouse model of Alzheimer’s disease
por: Gustavsson, Tobias, et al.
Publicado: (2020)

Transferrin Receptor Binding BBB-Shuttle Facilitates Brain Delivery of Anti-Aβ-Affibodies
por: Faresjö, Rebecca, et al.
Publicado: (2022)

Long-Term Effects of Traumatic Brain Injury in a Mouse Model of Alzheimer’s Disease
por: Zyśk, Marlena, et al.
Publicado: (2019)

Antibody-based PET imaging of amyloid beta in mouse models of Alzheimer's disease
por: Sehlin, Dag, et al.
Publicado: (2016)

On The Rate and Extent of Drug Delivery to the Brain
por: Hammarlund-Udenaes, Margareta, et al.
Publicado: (2007)

Development of brain-penetrable antibody radioligands for in vivo PET imaging of amyloid-β and tau
por: Banka, Vinay, et al.
Publicado: (2023)

A Brain-Targeting Bispecific-Multivalent Antibody Clears Soluble Amyloid-Beta Aggregates in Alzheimer’s Disease Mice
por: Rofo, Fadi, et al.
Publicado: (2022)

Efficient clearance of Aβ protofibrils in AβPP-transgenic mice treated with a brain-penetrating bifunctional antibody
por: Syvänen, Stina, et al.
Publicado: (2018)

Bivalent Brain Shuttle Increases Antibody Uptake by Monovalent Binding to the Transferrin Receptor
por: Hultqvist, Greta, et al.
Publicado: (2017)

Efficient and inexpensive transient expression of multispecific multivalent antibodies in Expi293 cells
por: Fang, Xiaotian T., et al.
Publicado: (2017)

Enhanced neprilysin-mediated degradation of hippocampal Aβ42 with a somatostatin peptide that enters the brain
por: Rofo, Fadi, et al.
Publicado: (2021)

Preclinical Pharmacokinetic Considerations for the Development of Antibody Drug Conjugates
por: Kamath, Amrita V., et al.
Publicado: (2014)

Translational Preclinical Pharmacologic Disease Models for Ophthalmic Drug Development
por: Shah, Mihir, et al.
Publicado: (2019)

Delineating Amyloid Plaque Associated Neuronal Sphingolipids in Transgenic Alzheimer’s Disease Mice (tgArcSwe) Using MALDI Imaging Mass Spectrometry
por: Kaya, Ibrahim, et al.
Publicado: (2016)

Synthesis of two potential NK(1)-receptor ligands using [1-(11)C]ethyl iodide and [1-(11)C]propyl iodide and initial PET-imaging
por: Syvänen, Stina, et al.
Publicado: (2007)

Is There a Space-Based Technology Solution to Problems with Preclinical Drug Toxicity Testing?
por: Hammond, Timothy, et al.
Publicado: (2016)

Using the Lessons Learned From the Clinic to Improve the Preclinical Development of Antibody Drug Conjugates
por: Jackson, Dowdy, et al.
Publicado: (2014)

Topical Drug Delivery to the Posterior Segment of the Eye: Addressing the Challenge of Preclinical to Clinical Translation
por: Rodrigues, Gerard A., et al.
Publicado: (2018)

Blood–brain barrier penetrating neprilysin degrades monomeric amyloid-beta in a mouse model of Alzheimer’s disease
por: Rofo, Fadi, et al.
Publicado: (2022)

Actionable imaging findings in the daily PET/CT scenario
por: Mattana, Francesco, et al.
Publicado: (2023)

SPECT vs. PET in cardiac innervation imaging: clash of the titans
por: Werner, Rudolf A., et al.
Publicado: (2018)

Amino acid PET and MR perfusion imaging in brain tumours
por: Filss, Christian P., et al.
Publicado: (2017)

Breast cancer: initial workup and staging with FDG PET/CT
por: Groheux, David, et al.
Publicado: (2021)

The development and validation of tau PET tracers: current status and future directions
por: Okamura, Nobuyuki, et al.
Publicado: (2018)

Synthesis and preliminary preclinical evaluation of fluorine-18 labelled isatin-4-(4-methoxyphenyl)-3-thiosemicarbazone ([(18)F]4FIMPTC) as a novel PET tracer of P-glycoprotein expression
por: Verbeek, Joost, et al.
Publicado: (2018)

State of the art of (18)F-FDG PET/CT application in inflammation and infection: a guide for image acquisition and interpretation
por: Casali, Massimiliano, et al.
Publicado: (2021)

Treatment of complex urethral stenosis in public centers from developing countries in 21st century
por: Tucci, Silvio, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gptjb6ju1s760n7odoivipscu2